Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals

Gene Therapy

Volumn 6, Issue 5, 1999, Pages 785-791

  MacLaren, D C ^a   Gambhir, S S ^a   Satyamurthy, N ^a   Barrio, J R ^a   Sharfstein, S ^a   Toyokuni, T ^a   Wu, L ^a   Berk, A J ^a   Cherry, S R ^a   Phelps, M E ^a   Herschman, H R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine receptor; Positron emission tomography; Reporter gene

Indexed keywords

3 (2 FLUOROETHYL)SPIPERONE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORINE 18; MESSENGER RNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENE TRANSFER; IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR GENE; REPORTER GENE; TUMOR;

ADENOVIRIDAE; ANIMALS; DOPAMINE ANTAGONISTS; FLUORESCENT DYES; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; LIVER; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SPIPERONE; TOMOGRAPHY, EMISSION-COMPUTED;

ADENOVIRIDAE; ANIMALIA; EUKARYOTA; TUMOR VIRUS;

EID: 6544233317     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300877     Document Type: Article

References (44)

1. Chalfie M et al. Green fluorescent protein as a marker for gene expression. Science 1989; 263: 802-805.
2. Chalfie M. Green fluorescent protein. Photochem Photobio 1995; 62: 651-656.
3. Bennett J, Duan D, Engelhardt JF, Maguire AM. Real-time, non-invasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci 1997; 38: 2857-2863.
4. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nature Med 1998; 4: 245-247.
5. Phelps MC. PET: a biological imaging technique. Neurochemical Res 1991; 16: 929-940.
6. Gambhir SS et al. Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 1998; 30: 2003-2011.
7. Barrio JR, Namavari M, Phelps ME, Satyamurthy N. Regioselective fluorination of substituted guanines with dilute F2: a facile entry to 8-fluoroguanine derivatives. J Org Chem 1996; 61: 6084-6085.
8. Tjuvajev JG et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 1996; 56: 4087-4095.
9. Tjuvajev JG et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998; 58: 4333-4341.
10. Haberkorn U et al. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med 1997; 38: 287-294.
11. Haberkorn U et al. Monitoring of gene therapy with cytosine deaminase: in vitro studies using 3H-5-fluorocytosine. J Nucl Med 1996; 37: 87-94.
12. Monclus M et al. Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: synthesis and in vitro evaluation of 9-{(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl}guanine. Bioorg Med Chem Lett 1997; 7: 1879-1882.
13. Alauddin MM et al. 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nuc Med Biol 1996; 23: 787-792.
14. 18F]Fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cerbral Blood Flow Metab 1989; 9: 830-839.
15. 18F]Fluoroethyl)spiperone examined by positron emission tomography. J Cerebral Blood Flow Metab 1989; 9: 840-849.
16. 18F]Fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in vivo utilization in humans. Appl Radiat Isotopes Int J Radiat Appl Instrument Part A 1990; 41: 113-129.
17. 2 dopamine receptor cDNA. Nature 1988; 367: 783-787.
18. Missale C et al. Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225.
19. Creese I. Neurochemical, behavioral, and clinical perspectives. In: Coyle JT, Enna SJ (eds). Neuroleptics. Raven Press: New York, 1983, pp 208-211.
20. Shaked A et al. Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 1994; 57: 1508-1511.
21. Herz J, Girard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812-2816.
22. Cherry SR et al. MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci 1997; 44: 1161-1166.
23. Seeman P. Brain dopamine receptors. Pharm Rev 1981; 32: 229-313.
24. 2 receptor cDNA expressed in a mammalian cell line. Mol Pharmacol 1989; 36: 446-451.
25. c-src can induce focus formation without complete transformation of NIH 3T3 cells. Mol Cell Biol 1983; 5: 1073-1083.
26. Phelps ME et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
27. Ehrin E et al. Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot 1985; 36: 269-273.
28. 2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 559-568.
29. Hume SP et al. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 1992; 12: 47-54.
30. Wagner HN et al. Imaging dopamine receptors in the human brain by positron tomography. Science 1983; 221: 1264-1266.
31. 2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med 1991; 32: 1593-1600.
32. 2 dopamine receptor. TINS 1990; 13: 373-378.
33. Neve KA et al. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol 1991; 39: 733-739.
34. 2 dopamine receptor using site-directed mutagenesis. J Neurochem 1996; 66: 394-402.
35. 2 receptors. J Neurochem 1992; 59: 627-635.
36. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 3346-3351.
37. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
38. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.
39. Veelken H et al. Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo. Hum Gene Ther 1996; 7: 1827-1836.
40. Gurtu V, Yan G, Zhang G. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines. Biochem Biophys Res Commun 1996; 229: 295-298.
41. Hsieh CL et al. Improved gene expression by a modified bicistronic retroviral vector. Biochem Biophys Res Commun 1995; 214: 910-917.
42. Sokolic RA et al. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood 1996; 87: 42-50.
43. Gomez-Foix AM et al. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem 1992; 267: 25129-25134.
44. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989.